Approved Drugs for Otolaryngology
Astepro (azelastine hydrochloride nasal spray); Meda Pharmaceuticals;
For the treatment of seasonal and perennial allergic rhinitis, Approved October 2008
Moxatag (amoxicillin); MiddleBrooke Pharmaceuticals;
For the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatrics, Approved January 2008
Patanase (olopatadine hydrochloride); Alcon;
For the treatment of seasonal allergic rhinitis, Approved April 2008
Veramyst (fluticasone furoate); GlaxoSmithKline;
For the treatment of seasonal and perennial allergic rhinitis, Approved April 2007
Xyzal (levocetirizine dihydrochloride); UCB;
For the treatment of seasonal and perennial allergic rhinitis and urticaria, Approved May 2007
Depakote ER (divalproex sodium); Abbott Laboratories;
For the prophylaxis (prevention) of migraine headaches in adults, Approved August 2000
Protonix (pantoprazole sodium) Delayed-Release Tablets; Wyeth;
For treatment of erosive esophagitis, Approved February 2000
Tri-Nasal Spray (triamcinolone acetonide spray); Muro Pharmaceutical;
For treatment of nasal symptoms of allergic rhinitis in adults and children age 12 or older, Approved February 2000
Ethyol (amifostine); U.S. Bioscience, Alza;
Treatment for xerostomia (dry mouth) due to radiation, Approved June 1999
Rocephin; Roche;
Treatment for acute otitis media, Approved January 1998
Rocephin; Roche;
Treatment for pediatric otitis media, Approved January 1998
Floxin otic; Daiichi Sankyo;
Treatment for otitis media, Approved December 1997
Omnicef; Warner-Lambert;
Treatment against various bacterias, Approved December 1997
Bactroban Nasal 2% (mupirocin calcium ointment); SmithKline Beecham;
Treatment for nasal bacteria, Approved April 1996
Cedax (ceftibuten); Schering-Plough;
Treatment for chronic bronchitis, acute bacterial otitis media, pharyngitis/tonsillitis, Approved December 1995
